Health
Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia – MD Linx
MDLinx original journal summary on Pneumonia, Infectious Disease from International Journal of Infectious Diseases
In the treatment of severe SARS-CoV-2 pneumonia (SSP), tocilizumab has been used with the aim to relieve the cytokine release syndrome (CRS)-induced acute respiratory distress syndrome (ARDS). Researchers here investigated the patients in whom it might benefit the most. Tocilizumab on a compassionate-use basis was provided to hospitalized patients with SSP (excluding intensive care and intubated cases) who required oxygen support to have a saturation > 93%. They studied a total of 207 patients and…
-
Noosa News9 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News10 hours agoMotorcyclist dies in crash with truck
-
General24 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General15 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging